To the full analysis
Buyback calculator for Opus Genetics
Opus Genetics stock: key metrics
IRDOpus Genetics had an operating margin of −271.9% and a return on invested capital (ROIC) of −89.6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2019 | no data | no data | no data |
| 2020 | no data | no data | no data |
| 2021 | 100.0% | −3,854.8% | −9,625.3% |
| 2022 | 100.0% | 45.7% | 44.9% |
| 2023 | 100.0% | −55.5% | −52.4% |
| 2024 | 100.0% | −564.7% | −523.4% |
| 2025 | 100.0% | −271.9% | −349.3% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2019 | 81.6% | no data | −100.0% |
| 2020 | 182.8% | no data | −100.0% |
| 2021 | −100.0% | −96.3% | −100.0% |
| 2022 | 38.7% | 51.9% | 36.5% |
| 2023 | −20.0% | −17.4% | −18.5% |
| 2024 | −100.0% | no data | −100.0% |
| 2025 | −100.0% | −89.6% | −98.7% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 20 Feb 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.